Literature DB >> 8406587

Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.

G M Halliday1, A D Lucas.   

Abstract

Langerhans' cells (LC) take up antigen in the epidermis and then migrate to the local lymph nodes where they present the antigen to T lymphocytes, initiating cutaneous immune responses. However the intracellular mechanisms which mediate LC migration from the epidermis are unknown. We have demonstrated that activation of protein kinase C (PKC) induces this LC migration. An analogue of diacylglycerol (DAG), the physiological activator of PKC, L-alpha-dioctanoyl glycerol (oDAG), applied topically onto the skin of mice caused a significant depletion in the density of Ia+ and J11d+ epidermal LC. oDAG decreased the density of LC in both BALB/c and C57BL mice 24 hr following application, over a dose range of 0.5-24 microM; 200 or 0.05 microM being ineffective. LC density remained depressed for up to 7 days and oDAG increased the number of fluorescein isothiocyanate (FITC) positive cells in the local lymph nodes of mice treated topically with FITC, indicating that oDAG induced LC migration from the epidermis. Additionally, LC migration from the epidermis induced by the contact sensitizer 2,4,6-trinitrochlorobenzene (TNCB) was blocked when PKC was inhibited by palmitoyl-DL-carnitine chloride (PCC) or D-Sphingosine (Sph), indicating that LC cannot migrate from the epidermis when PKC is inhibited. However, PCC did not inhibit the induction of contact sensitivity. Thus PKC transduces the signal which leads to LC migration from the epidermis, and disruptions in this secondary messenger may interfere with the induction of immune responses in the skin by disturbing LC migration from the epidermis to the local lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406587      PMCID: PMC1421922     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

Review 1.  Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes.

Authors:  J W Streilein; S F Grammer; T Yoshikawa; A Demidem; M Vermeer
Journal:  Immunol Rev       Date:  1990-10       Impact factor: 12.988

2.  The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus.

Authors:  M Crowley; K Inaba; M Witmer-Pack; R M Steinman
Journal:  Cell Immunol       Date:  1989-01       Impact factor: 4.868

3.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization.

Authors:  M L Kripke; C G Munn; A Jeevan; J M Tang; C Bucana
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

4.  Correlation between lymphocyte proliferative responses and dendritic cell migration in regional lymph nodes following skin painting with contact-sensitizing agents.

Authors:  I Kimber; A Kinnaird; S W Peters; J A Mitchell
Journal:  Int Arch Allergy Appl Immunol       Date:  1990

5.  Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.

Authors:  G Brooks; R E Wilson; T P Dooley; M W Goss; I R Hart
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

6.  MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.

Authors:  M Cumberbatch; S J Gould; S W Peters; I Kimber
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

7.  Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

8.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

9.  Expression of protein kinase C isozyme in epidermal Langerhans cells of the mouse.

Authors:  Y Koyama; T Hachiya; M Hagiwara; M Kobayashi; K Ohashi; T Hoshino; H Hidaka; T Marunouchi
Journal:  J Invest Dermatol       Date:  1990-05       Impact factor: 8.551

10.  Antigen presented in the local lymph node by cells from dimethylbenzanthracene-treated murine epidermis activates suppressor cells.

Authors:  G M Halliday; L L Cavanagh; H K Muller
Journal:  Cell Immunol       Date:  1988-12       Impact factor: 4.868

View more
  7 in total

1.  Protein-kinase-specific inhibitors block Langerhans' cell migration by inhibiting interleukin-1alpha release.

Authors:  G Shankar; J Johnson; L Kuschel; M Richins; K Burnham
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

2.  Role of Protein Kinase C in Immune Cell Activation and Its Implication Chemical-Induced Immunotoxicity.

Authors:  Emanuela Corsini; Erica Buoso; Valentina Galbiati; Marco Racchi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

4.  Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.

Authors:  D I Gabrilovich; G M Woods; S Patterson; J J Harvey; S C Knight
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

5.  Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha.

Authors:  M Cumberbatch; I Fielding; I Kimber
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

6.  Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.

Authors:  V Angeli; C Faveeuw; O Roye; J Fontaine; E Teissier; A Capron; I Wolowczuk; M Capron; F Trottein
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

Review 7.  Loricrin: Past, Present, and Future.

Authors:  Yosuke Ishitsuka; Dennis R Roop
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.